Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia

Clinical Immunology

Volumn 139, Issue 1, 2011, Pages 48-56

  Molvarec, Attila ^a   Blois, Sandra M ^b   Stenczer, Balázs ^a   Toldi, Gergely ^c   Tirado Gonzalez, Irene ^b   Ito, Mika ^d   Shima, Tomoko ^d   Yoneda, Satoshi ^d   Vásárhelyi, Barna ^c   Rigó, János ^a   Saito, Shigeru ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiogenic factor; Autoantibody; Galectin 1; Inflammation; Lymphocyte; Preeclampsia; Pregnancy

Indexed keywords

AUTOANTIBODY; GALECTIN 1; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD; CELL ACTIVATION; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AUTOANTIBODIES; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES;

EID: 79953026900     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.12.018     Document Type: Article

References (44)

1. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565.
2. Sasaki Y., Darmochwal-Kolarz D., Suzuki D., Sakai M., Ito M., Shima T., Shiozaki A., Rolinski J., Saito S. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 2007, 149:139-145.
3. Steinborn A., Haensch G.M., Mahnke K., Schmitt E., Toermer A., Meuer S., Sohn C. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia?. Clin. Immunol. 2008, 129:401-412.
4. Santner-Nanan B., Peek M.J., Khanam R., Richarts L., Zhu E., Fazekas de St Groth B., Nanan R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 2009, 183:7023-7030.
5. Darmochwal-Kolarz D., Rolinski J., Leszczynska-Goarzelak B., Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am. J. Reprod. Immunol. 2002, 48:381-386.
6. Saito S., Sakai M. Th1/Th2 balance in preeclampsia. J. Reprod. Immunol. 2003, 59:161-173.
7. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 1998, 179:1359-1375.
8. Camby I., Le Mercier M., Lefranc F., Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006, 16:137R-157R.
9. Blaser C., Kaufmann M., Muller C., Zimmermann C., Wells V., Mallucci L., Pircher H. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 1998, 28:2311-2319.
10. Zuniga E., Rabinovich G.A., Iglesias M.M., Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J. Leukoc. Biol. 2001, 70:73-79.
11. Koopman L.A., Kopcow H.D., Rybalov B., Boyson J.E., Orange J.S., Schatz F., Masch R., Lockwood C.J., Schachter A.D., Park P.J., Strominger J.L. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 2003, 198:1201-1212.
12. Rabinovich G.A., Iglesias M.M., Modesti N.M., Castagna L.F., Wolfenstein-Todel C., Riera C.M., Sotomayor C.E. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J. Immunol. 1998, 160:4831-4840.
13. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 1995, 378:736-739.
14. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834.
15. Dias-Baruffi M., Zhu H., Cho M., Karmakar S., McEver R.P., Cummings R.D. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J. Biol. Chem. 2003, 278:41282-41293.
16. Chung C.D., Patel V.P., Moran M., Lewis L.A., Miceli M.C. Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J. Immunol. 2000, 165:3722-3729.
17. Rabinovich G.A., Ariel A., Hershkoviz R., Hirabayashi J., Kasai K.I., Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 1999, 97:100-106.
18. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 1999, 190:385-398.
19. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., Hirabayashi J., Rizzo L.V., Rabinovich G.A. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006, 176:6323-6332.
20. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., Tirado I., Markert U.R., Klapp B.F., Poirier F., Szekeres-Bartho J., Rabinovich G.A., Arck P.C. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
21. Joubert K. Standards of the body mass and body length of birth in Hungary on the basis of the 1990-1996 nation-wide liveborn data. Magy. Noorv. L. 2000, 63:155-163.
22. Kopcow H.D., Rosetti F., Leung Y., Allan D.S., Kutok J.L., Strominger J.L. T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18472-18477.
23. Molvarec A., Szarka A., Walentin S., Szucs E., Nagy B., Rigo J. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens. Res. 2010, 33:892-898.
24. Choe Y.S., Shim C., Choi D., Lee C.S., Lee K.K., Kim K. Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. Mol. Reprod. Dev. 1997, 48:261-266.
25. von Wolff M., Wang X., Gabius H.J., Strowitzki T. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol. Hum. Reprod. 2005, 11:189-194.
26. Than N.G., Romero R., Erez O., Weckle A., Tarca A.L., Hotra J., Abbas A., Han Y.M., Kim S.S., Kusanovic J.P., Gotsch F., Hou Z., Santolaya-Forgas J., Benirschke K., Papp Z., Grossman L.I., Goodman M., Wildman D.E. Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15819-15824.
27. Terness P., Kallikourdis M., Betz A.G., Rabinovich G.A., Saito S., Clark D.A. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol. 2007, 58:238-254.
28. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
29. Roberts J.M., Gammill H.S. Preeclampsia: recent insights. Hypertension 2005, 46:1243-1249.
30. Iida A., Ozaki K., Tanaka T., Nakamura Y. Fine-scale SNP map of an 11-kb genomic region at 22q13.1 containing the galectin-1 gene. J. Hum. Genet. 2005, 50:42-45.
31. Molvarec A., Jermendy A., Nagy B., Kovacs M., Varkonyi T., Hupuczi P., Prohaszka Z., Rigo J. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin. Chim. Acta 2008, 392:52-57.
32. Molvarec A., Rigo J., Lazar L., Balogh K., Mako V., Cervenak L., Mezes M., Prohaszka Z. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009, 14:151-159.
33. Rosta K., Molvarec A., Enzsoly A., Nagy B., Ronai Z., Fekete A., Sasvari-Szekely M., Rigo J., Ver A. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 142:134-138.
34. Molvarec A., Kalabay L., Derzsy Z., Szarka A., Halmos A., Stenczer B., Arnaud P., Karadi I., Prohaszka Z., Rigo J. Preeclampsia is associated with decreased serum alpha(2)-HS glycoprotein (fetuin-A) concentration. Hypertens. Res. 2009, 32:665-669.
35. Nagy B., Varkonyi T., Molvarec A., Lazar L., Hupuczi P., Than N.G., Rigo J. Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome. Clin. Chem. Lab. Med. 2009, 47:1033-1037.
36. Jeschke U., Mayr D., Schiessl B., Mylonas I., Schulze S., Kuhn C., Friese K., Walzel H. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007, 28:1165-1173.
37. Than N.G., Erez O., Wildman D.E., Tarca A.L., Edwin S.S., Abbas A., Hotra J., Kusanovic J.P., Gotsch F., Hassan S.S., Espinoza J., Papp Z., Romero R. Severe preeclampsia is characterized by increased placental expression of galectin-1. J. Matern. Fetal. Neonatal. Med. 2008, 21:429-442.
38. Iwamoto M., Taguchi C., Sasaguri K., Kubo K.Y., Horie H., Yamamoto T., Onozuka M., Sato S., Kadoya T. The Galectin-1 level in serum as a novel marker for stress. Glycoconj. J. 2010, 27:419-425.
39. Le Q.T., Shi G., Cao H., Nelson D.W., Wang Y., Chen E.Y., Zhao S., Kong C., Richardson D., O'Byrne K.J., Giaccia A.J., Koong A.C. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J. Clin. Oncol. 2005, 23:8932-8941.
40. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., Baur E., Nissen E., Vetter K., Neichel D., Dudenhausen J.W., Haller H., Luft F.C. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 1999, 103:945-952.
41. Verlohren S., Muller D.N., Luft F.C., Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009, 54:439-443.
42. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am. J. Obstet. Gynecol. 2007, 196(5):e1-7.
43. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., Epstein F.H., Sukhatme V.P., Karumanchi S.A. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003, 111:649-658.
44. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350:672-683.